Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Users of Mass Spectrometers in the U.S.(?)

Council Members in this Study Group: 73

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

What is a GLG Leader?
John Waugh, Director of System Laboratory Operations, Henry Ford Health SystemJohn Waugh
Director of System Laboratory Operations
Henry Ford Health System

John Waugh is Director of System Laboratory Operations at Henry Ford Health System in Detroit, the 12th largest US hospital laboratory, research & and academic medical center. Mr. Waugh has expertise in new and emerging clinical and molecular diagnostic systems, including products and services from...

Stan Schofield, MS, MHA,MT(ASCP), Managing Principal, The Compass Group, ScarboroughStan Schofield, MS, MHA,MT(ASCP)
Managing Principal
The Compass Group, Scarborough

Stan Schofield, MS, MHA, MT (ASCP), is President of NorDx, a regional laboratory corporation which is part of the Maine Health System. He also serves as a senior member of the health system executive management team. Mr. Schofield is the Managing Principal of the Compass Group, a confederation of 18...

Shane Needham, PhD
Laboratory Director
Alturas Analytics Inc

Shane Needham, PhD, is the Laboratory Director at Alturas Analytics. He has over 16 years of experience in analytical laboratories. Dr. Needham has over 18 years of analytical laboratory experience in the pharmaceutical industry and CRO industry using HPLC and MS. He previously worked for Pfizer before...

Gregory Khitrov, PhD, Director of Personalized Medicine Program, MOUNT SINAI SCHOOL OF MEDICINE Gregory Khitrov, PhD
Director of Personalized Medicine Program
MOUNT SINAI SCHOOL OF MEDICINE

Greg Khitrov, PhD, is the Director of Life Sciences Technology Center at the Institute for Personalized Medicine, Director of Biobank and an Assistant Professor of Medicine at the Mount Sinai School of Medicine in New York. He has expertise in molecular biology; proteomics; and laboratory automation...

Mark Tapsak, PhD, Assistant Professor, Bloomsburg University of Pennsylvania IncMark Tapsak, PhD
Assistant Professor
Bloomsburg University of Pennsylvania Inc

Mark Tapsak, PhD, is an Assistant Professor of Chemistry at Bloomsburg University of Pennsylvania. Prior to joining Bloomsburg University, he was a Senior Scientist at DexCom in San Diego, CA. Dr. Tapsak has also worked for Medtronic in Minneapolis, MN. His academic experience centers on polymer synthesis,...

GLG NewsSMAnalyses by this Study Group's Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
New Mass Spectrometers Introduced and Current Use of "UPLC" from Recent American Society on Mass Spectrometry Conference | 06-10-2008
Author: Shane Needham, PhD, Laboratory Director , Alturas Analytics Inc

The recent ASMS conference show cased several vendors including Thermo, Waters and Agilent that introduced new triple quadrupole mass spectrometers that are meant to compete with the API4000 and API5000 from Applied Biosystems.  This could change the competitive landscape in the quantitative bioanalysis...

Industry leaders need to work with the US Patent and Trademark office to keep US patents strong | 04-24-2008
Author: Mark Tapsak, PhD, Assistant Professor, Bloomsburg University of Pennsylvania Inc

The USPTO is facing an epidemic amount of frivolous patents.  This degrades their ability to review strong and potentially important patents in a timely manner.  Although this particular change was struck down in Federal court, industry leaders need to work with the USPTO in order...

CooperVision enters US market with Avaira™ two-week silicone hydrogel contact lenses | 04-16-2008
Author: Mark Tapsak, PhD, Assistant Professor, Bloomsburg University of Pennsylvania Inc

I’m not so sure that this is a leap forward for CooperVision.  After long delays for the release of the Biofinity lens, a two-week version has just been released.  The material properties are reportedly “nice”, but certainly scaled back from what was reportedly achieved with Comfilcon...

DexCom Makes Progress Towards Easier Glucose Monitoring | 11-19-2007
Author: Mark Tapsak, PhD, Assistant Professor, Bloomsburg University of Pennsylvania Inc

It's not easy being small, especially in the world of medical devices. Big players leverage branding, large sales forces and deep R&D organizations when they bring technologies to market. Unfortunately, most products are incremental improvements at best. Rarely does the conservative healthcare market benefit...

All plastics are not created equal, choose wisely young biomedical engineer | 10-22-2007
Author: Mark Tapsak, PhD, Assistant Professor, Bloomsburg University of Pennsylvania Inc

Material choices for the designer of medical devices are traditionally limited to those that already enjoy a proven track record. The use of truly new materials in a medical device is not only risky for the device manufacturer, but also for the material manufacturer. In particular, tissue contacting...

View All GLG News by members of this Study Group

GLG InstituteSM Seminars with this Study Group's Leaders(?)

 

Recent Seminars

GLGi: Genotyping Technologies
New York, 04-26-2007

Most Common Company Types:

  • Pharmaceuticals Manufacturer
  • Academic Medical Center/Hospital or Clinic
  • Academic Institution*
  • Biotechnology Manufacturer
  • Lab, Academic Medical Center
  • Pharmaceuticals/Biotechnology Research Services
  • Laboratory, Independent

Most Common Job Types:

  • Director
  • Research Scientist
  • Researcher
  • Professor
  • President
  • Physician - Director
  • Physician - Department Chair

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics